191 tracked 13F filers disclose a position in ARVN as of the latest SEC 13F filings, a combined $519.7M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | $72.1M | 6.8M | ▼−7.2% Reduced · −525K sh | Q1 2026 | |
| 2 | VANGUARD PORTFOLIO MANAGEMENT LLC | $41.2M | 3.9M | →First observed position No prior filed position | Q1 2026 | |
| 3 | D. E. Shaw & Co., Inc. | $38.6M | 3.6M | ▼−1.4% Reduced · −51K sh | Q1 2026 | |
| 4 | PFIZER INC | $29.5M | 3.5M | —Held | Q3 2025 | |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | $28.5M | 2.7M | →First observed position No prior filed position | Q1 2026 | |
| 6 | TCG Crossover Management, LLC | $25.3M | 2.4M | ▼−10% Reduced · −279K sh | Q1 2026 | |
| 7 | STATE STREET CORP | $18.3M | 2.2M | ▲+20% Added · +368K sh | Q2 2026 | |
| 8 | ARMISTICE CAPITAL, LLC | $21.0M | 2.0M | ▲+9.9% Added · +178K sh | Q1 2026 | |
| 9 | TWO SIGMA INVESTMENTS, LP | $19.4M | 1.8M | ▲+85% Added · +840K sh | Q1 2026 | |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | $13.9M | 1.7M | ▲+7.1% Added · +110K sh | Q2 2026 | |
| 11 | JACOBS LEVY EQUITY MANAGEMENT, INC | $15.3M | 1.4M | ▲+471% Added · +1.2M sh | Q1 2026 | |
| 12 | Qube Research & Technologies Ltd | $12.7M | 1.2M | ▼−9.3% Reduced · −123K sh | Q1 2026 | |
| 13 | FEDERATED HERMES, INC. | $12.1M | 1.1M | ▲+4.2% Added · +46K sh | Q1 2026 | |
| 14 | Vestal Point Capital, LP | $9.6M | 905K | ▲New +905K sh | Q1 2026 | |
| 15 | GOLDMAN SACHS GROUP INC | $8.0M | 757K | ▼−32% Reduced · −359K sh | Q1 2026 | |
| 16 | MORGAN STANLEY | $7.2M | 675K | ▼−17% Reduced · −135K sh | Q1 2026 | |
| 17 | CITADEL ADVISORS LLC | $5.2M | 621K | ▼−47% Reduced · −560K sh | Q2 2026 | |
| 18 | MILLENNIUM MANAGEMENT LLC | $6.1M | 576K | ▼−54% Reduced · −683K sh | Q1 2026 | |
| 19 | KENNEDY CAPITAL MANAGEMENT LLC | $5.9M | 553K | ▲+25% Added · +110K sh | Q1 2026 | |
| 20 | Nextech Invest Ltd. | $5.7M | 539K | —Held | Q1 2026 | |
| 21 | TANG CAPITAL MANAGEMENT LLC | $5.7M | 539K | ▼−5.4% Reduced · −31K sh | Q1 2026 | |
| 22 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $5.6M | 525K | ▼−4.1% Reduced · −22K sh | Q1 2026 | |
| 23 | NORTHERN TRUST CORP | $5.5M | 521K | ▼−4.8% Reduced · −27K sh | Q1 2026 | |
| 24 | DIMENSIONAL FUND ADVISORS LP | $5.1M | 486K | ▲+2.8% Added · +13K sh | Q1 2026 | |
| 25 | NORDEA INVESTMENT MANAGEMENT AB | $5.1M | 475K | ▼−4.2% Reduced · −21K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 6 funds opened a new position in ARVN and 26 added to an existing one, while 19 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| AMAZON.COM INCAMZN | 90 funds | $134.4B |
| META PLATFORMS INC-CLASS AMETA | 90 funds | $76.9B |
| MICROSOFT CORPMSFT | 89 funds | $186.9B |
| ELI LILLY & COLLY | 89 funds | $53.6B |
| NVIDIA CORPNVDA | 88 funds | $275.2B |
| MICRON TECHNOLOGY INCMU | 88 funds | $26.2B |
| ALPHABET INC-CL AGOOGL | 87 funds | $106.6B |
| COSTCO WHOLESALE CORPCOST | 86 funds | $24.4B |
| BOSTON SCIENTIFIC CORPBSX | 86 funds | $10.9B |
| CME GROUP INCCME | 86 funds | $8.5B |
| CENTENE CORPCNC | 86 funds | $3.3B |
| INTUITIVE SURGICAL INCISRG | 85 funds | $19.4B |
Ranked by how many of ARVN's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Jun 24, 2026 | Saik Andrew | Chief Financial Officer | Sell (S) | 6K | $46K |
| Jun 17, 2026 | Cacace Angela M | Chief Scientific Officer | Sell (S) | 3K | $20K |
| May 21, 2026 | Teel Randy | President and CEO, Director | Sell (S) | 2K | $20K |
| May 11, 2026 | Teel Randy | President and CEO, Director | Sell (S) | 10K | $96K |
| May 11, 2026 | Berkowitz Noah | Chief Medical Officer | Sell (S) | 11K | $110K |
| May 11, 2026 | Cacace Angela M | Chief Scientific Officer | Sell (S) | 10K | $96K |
| May 11, 2026 | Loomis David K | VP, Chief Accounting Officer | Sell (S) | 2K | $19K |
| May 11, 2026 | Saik Andrew | Chief Financial Officer | Sell (S) | 11K | $111K |
| Mar 18, 2026 | Berkowitz Noah | Chief Medical Officer | Sell (S) | 6K | $71K |
| Mar 6, 2026 | Morrison Briggs | Director | Buy (P) | 20K | $268K |
| Feb 27, 2026 | Houston John G | Director | Sell (S) | 5K | $62K |
| Feb 27, 2026 | Houston John G | Director | Sell (S) | 19K | $249K |
Connected entities for ARVN
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/ARVN/capital-change-brief"
Use Arkolith's capital_change_brief for ARVN. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for ARVN. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.